DrugRisk Alert: Court Reports Jump In Januvia Lawsuits Alleging Cancer

Share Article

DrugRisk is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

januvia lawsuit
Anyone affected by cancer after taking Januvia or Janumet is encouraged to speak with a lawyer about their legal options.

DrugRisk.com’s diabetes drug safety center is alerting patients taking the medications Januvia or Janumet of new information on the site. Updated records from a special federal court show the number of lawsuits alleging drugs like Januvia caused pancreatic cancer have more than doubled in the past month*.

The DrugRisk Center is provided as a free resource for those taking popular prescription drugs. By learning the latest product recalls, safety alerts, research and litigation news, patients can avoid dangerous drugs, see if others are experiencing similar side effects and decide if they need legal advice.

Januvia and Janumet are popular oral diabetes medications prescribed to those with type-2 diabetes, taken twice a day to lower blood sugar levels. In recent years, they have been the best-selling drugs for pharmaceutical company Merck**.

However, DrugRisk has added studies warning of a risk of Januvia cancer. In 2011, researchers from UCLA discovered subjects given Januvia had increased rates of pancreatic cancer and thyroid cancer***. The American Medical Association recently advised diabetes drugs like these can double the risk of pancreatitis, a major risk factor for pancreatic cancer****.

Due to the number of patients who have filed a Januvia lawsuit alleging cancer, cases have been consolidated to a special federal multidistrict litigation court. (In Re: Incretin-Based Therapies Products Liability Litigation, MDL 2452, Southern District of California).

Now, the latest records from the Judicial Panel on Multidistrict Litigation show the number of cases filed alleging cancer from the drug class including Januvia, Byetta, Janumet or Victoza has grown quickly from 60 on September 11 to 150 on October 17*.

Anyone affected by cancer after taking Januvia or Janumet is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Januvia lawsuits.

For more information on the research, side effects and litigation news related to Januvia and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Judicial Panel on Multidistrict Litigation, 10/17/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-October-17-2013.pdf
**Bloomberg, 2/25/13; bloomberg.com/news/2013-02-25/merck-bristol-diabetes-drugs-linked-to-pancreatitis-risk.html
***Gastroenterology, July 2011; ctsi.ucla.edu/education/files/publicview/training/docs/FDA-analysis.pdf
****JAMA Internal Medicine, 2/25/13; archinte.jamanetwork.com/article.aspx?articleid=1656537

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chris Schroeder
DrugRisk
888-415-1859
Email >
Visit website